NASDAQ · YTEN
Basic Materials · Agricultural Inputs
$0.34
Down-$0.36 (-51.78%)
Updated Aug 15, 2026, 4:51 PM
SID Score
—
Composite research score
Smart Money
—
Institutional and insider signal
Price performance
1M range · 0 trading sessions · Daily adjusted prices
YTEN does not have enough price history for the selected period.
Data unavailable
Market data is busy. Please try again shortly.
The latest Smart Investors Daily articles mentioning YTEN.
YTEN research
Company profile and research snapshot.
Yield10 Bioscience, Inc., an agricultural bioscience company, engages in developing technologies to enable step-change increases in crop yield in the United States and Canada. The company, through its Trait Factory, a trait gene discovery platform develops enhanced oilseed Camelina sativa for the production of proprietary seed products; and discovers high value genetic traits for the agriculture and food industries. Yield10 Bioscience, Inc. has license agreements with GDM Seeds; J. R. Simplot; Forage Genetics International, LLC; and Bayer AG. The company was formerly known as Metabolix, Inc. and changed its name to Yield10 Bioscience, Inc. in January 2017. Yield10 Bioscience, Inc. was incorporate in 1992 and is headquartered in Woburn, Massachusetts.
Visit company websiteConsensus and target data currently published for this company.
| Date | Firm | Rating | Target |
|---|---|---|---|
| Feb 8, 2024 | Lake Street | Hold | — |
| Nov 16, 2023 | Maxim Group | Hold | — |
| Nov 16, 2023 | HC Wainwright & Co. | Buy | — |
| Aug 17, 2023 | HC Wainwright & Co. | Buy | — |
| Aug 16, 2023 | Lake Street | Buy | — |
No generated briefing is available yet.
GlobeNewswire Inc. · Jun 17, 2024
Engineered Camelina is intended to enable the land-based production of omega-3 oils used in aquafeed, petfood and human nutrition Engineered Camelina is intended to enable the land-based production of omega-3 oils used in aquafeed, petfood and human nutrition
GlobeNewswire Inc. · May 23, 2024
- EPA approved an amendment to the label of INTERLINE herbicideto include Camelina
GlobeNewswire Inc. · May 15, 2024
-Earns $1 million in milestone payments from Vision Bioenergy Oilseeds -Earns $1 million in milestone payments from Vision Bioenergy Oilseeds
GlobeNewswire Inc. · May 15, 2024
WOBURN, Mass., May 15, 2024 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (Nasdaq:YTEN) ("Yield10" or the "Company"), an agricultural bioscience company, today announced that Company has received a final delisting notice from Nasdaq. The delisting is a result of failure to regain compliance with the minimum stockholders’ equity requirement for continued listing on the Nasdaq Capital Market set forth in Nasdaq Listing Rule 5550(b)(1) requiring companies listed on the Nasdaq Capital Market to maintain stockholder’s equity of at least $2,500,000. Suspension of trading in the Company’s common stock on the Nasdaq exchange will be effective at the open of trading on May 16, 2024.
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
The latest Smart Investors Daily articles mentioning YTEN.
No results
No recent SID articles mention YTEN.
